{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T23:37:56Z","timestamp":1778024276653,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["305930"],"award-info":[{"award-number":["305930"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jamda.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jamda.2024.105151","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T03:18:00Z","timestamp":1720927080000},"page":"105151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Association of Dementia With Incident Adverse Drug Reactions in Hospitalized Older Adults"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-1602-8617","authenticated-orcid":false,"given":"Erick A.","family":"Rodriguez-Espeso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Verdejo-Bravo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Cherubini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adalsteinn","family":"Gudmundsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirko","family":"Petrovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy L.","family":"Soiza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"O'Mahony","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso J.","family":"Cruz-Jentoft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2024.105151_bib1","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1080\/14740338.2018.1497156","article-title":"A\u00a0narrative review of problems with medicines use in people with dementia","volume":"17","author":"Eshetie","year":"2018","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jamda.2024.105151_bib2","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/j.1365-2125.2012.04423.x","article-title":"Reasons that prevent the inclusion of Alzheimer\u2019s disease patients in clinical trials","volume":"75","author":"Rollin-Sillaire","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jamda.2024.105151_bib3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/2042098616670798","article-title":"Polypharmacy and inappropriate medication use in patients with dementia: an underresearched problem","volume":"8","author":"Parsons","year":"2017","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.jamda.2024.105151_bib4","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/gerona\/gly078","article-title":"The impact of dementia diagnosis on patterns of potentially inappropriate medication use among older adults","volume":"73","author":"Gnjidic","year":"2018","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jamda.2024.105151_bib5","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s41999-021-00502-7","article-title":"Potentially inappropriate medication among people with dementia: towards individualized decision-making","volume":"12","author":"Renom-Guiteras","year":"2021","journal-title":"Eur Geriatr Med"},{"key":"10.1016\/j.jamda.2024.105151_bib6","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/bcp.12596","article-title":"Adverse drug reactions in special populations - the elderly","volume":"80","author":"Davies","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jamda.2024.105151_bib7","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","article-title":"Adverse drug reactions: definitions, diagnosis, and management","volume":"356","author":"Edwards","year":"2000","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.jamda.2024.105151_bib8","doi-asserted-by":"crossref","first-page":"795","DOI":"10.7326\/0003-4819-140-10-200405180-00009","article-title":"Clarifying adverse drug events: a clinician\u2019s guide to terminology, documentation, and reporting","volume":"140","author":"Nebeker","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jamda.2024.105151_bib9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.regg.2009.10.002","article-title":"Recomendaciones en la prevenci\u00f3n de reacciones adversas a medicamentos en personas mayores con demencia","volume":"45","author":"G\u00f3mez-Pav\u00f3n","year":"2010","journal-title":"Rev Esp Geriatr Gerontol"},{"key":"10.1016\/j.jamda.2024.105151_bib10","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1345\/aph.1L037","article-title":"Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies","volume":"42","author":"Kongkaew","year":"2008","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jamda.2024.105151_bib11","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jagp.2016.07.002","article-title":"Risk factors for adverse drug reactions in older subjects hospitalized in a dedicated dementia unit","volume":"25","author":"Kanagaratnam","year":"2017","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2024.105151_bib12","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/bcp.14417","article-title":"Prevalence of adverse drug events and adverse drug reactions in hospital among older patients with dementia: a systematic review","volume":"87","author":"Sakiris","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jamda.2024.105151_bib13","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jamda.2011.04.006","article-title":"Geriatric conditions and adverse drug reactions in elderly hospitalized patients","volume":"13","author":"Lattanzio","year":"2012","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2024.105151_bib14","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00228-016-2084-3","article-title":"Drug-related hospital admissions among old people with dementia","volume":"72","author":"Gustafsson","year":"2016","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jamda.2024.105151_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph16060934","article-title":"Adverse drug events in patients with dementia and neuropsychiatric\/behavioral, and psychological symptoms, a one-year prospective study","volume":"16","author":"Hern\u00e1ndez","year":"2019","journal-title":"Int J Environ Res Publ Health"},{"key":"10.1016\/j.jamda.2024.105151_bib16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12877-019-1047-9","article-title":"The effect of SENATOR (Software ENgine for the Assessment and optimisation of drug and non-drug Therapy in Older peRsons) on incident adverse drug reactions (ADRs) in an older hospital cohort \u2013 trial Protocol","volume":"19","author":"Lavan","year":"2019","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.jamda.2024.105151_bib17","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/ageing\/afaa072","article-title":"Prevention of adverse drug reactions in hospitalized older patients with multi-morbidity and polypharmacy: the SENATOR\u2217 randomized controlled clinical trial","volume":"49","author":"O\u2019Mahony","year":"2020","journal-title":"Age Ageing"},{"key":"10.1016\/j.jamda.2024.105151_bib18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J\u00a0Psychiatr Res"},{"key":"10.1016\/j.jamda.2024.105151_bib19","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/ageing\/afu021","article-title":"Validation of the 4AT, a new instrument for rapid delirium screening: a study in 234 hospitalised older people","volume":"43","author":"Bellelli","year":"2014","journal-title":"Age Ageing"},{"key":"10.1016\/j.jamda.2024.105151_bib20","first-page":"379","article-title":"Cholinesterase inhibitors and memantine for the treatment of Alzheimer and non-Alzheimer dementias","volume":"74","author":"Bal\u00e1zs","year":"2021","journal-title":"Ideggyogyaszati Szle"},{"key":"10.1016\/j.jamda.2024.105151_bib21","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/jgs.17010","article-title":"MMSE cutoff discriminates hippocampal atrophy: neural evidence for the cutoff of 24 points","volume":"69","author":"Sakurai","year":"2021","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2024.105151_bib23","first-page":"2229","article-title":"Preventability and severity assessment in reporting adverse drug reactions","volume":"49","author":"Hartwig","year":"1992","journal-title":"Am J Hosp Pharm"},{"key":"10.1016\/j.jamda.2024.105151_bib24","first-page":"2079","article-title":"A\u00a0systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting","volume":"9","author":"Alhawassi","year":"2014","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.jamda.2024.105151_bib25","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.clinthera.2016.11.005","article-title":"Confounding variables and the performance of triggers in detecting unreported adverse drug reactions","volume":"39","author":"Varallo","year":"2017","journal-title":"Clin Therapeut"},{"key":"10.1016\/j.jamda.2024.105151_bib26","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1007\/s11845-023-03300-1","article-title":"Adverse drug reactions in geriatric psychiatry\u2014retrospective cohort study of a 6-year period","volume":"192","author":"Heck","year":"2023","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.jamda.2024.105151_bib27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.npg.2014.08.002","article-title":"Effets ind\u00e9sirables m\u00e9dicamenteux chez des sujets \u00e2g\u00e9s hospitalis\u00e9s dans une unit\u00e9 sp\u00e9cialis\u00e9e dans la prise en charge des patients atteints de syndrome d\u00e9mentiel","volume":"15","author":"Kanagaratnam","year":"2015","journal-title":"NPG Neurol - Psychiatr - G\u00e9riatrie"},{"key":"10.1016\/j.jamda.2024.105151_bib28","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s40266-014-0206-0","article-title":"Adverse drug reactions in elderly subjects hospitalized in a specialized dementia management unit","volume":"31","author":"Kanagaratnam","year":"2014","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jamda.2024.105151_bib29","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00228-002-0493-y","article-title":"Adverse drug reactions and cognitive function among hospitalized older adults","volume":"58","author":"Onder","year":"2002","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jamda.2024.105151_bib30","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1532-5415.1994.tb04974.x","article-title":"Symptom patterns and comorbidity in the early stages of alzheimer\u2019s disease","volume":"42","author":"McCormick","year":"1994","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2024.105151_bib31","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/jama.289.9.1107","article-title":"Incidence and preventability of adverse drug events among older persons in the ambulatory setting","volume":"289","author":"Gurwitz","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2024.105151_bib32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2147\/DHPS.S29287","article-title":"Adverse drug reactions in older patients: an Italian observational prospective hospital study","volume":"4","author":"Conforti","year":"2012","journal-title":"Drug Healthc Patient Saf"},{"key":"10.1016\/j.jamda.2024.105151_bib33","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.amjmed.2004.09.018","article-title":"The incidence of adverse drug events in two large academic long-term care facilities","volume":"118","author":"Gurwitz","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.jamda.2024.105151_bib34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.maturitas.2015.12.013","article-title":"Adverse drug reactions in elderly patients with cognitive disorders: a systematic review","volume":"85","author":"Kanagaratnam","year":"2016","journal-title":"Maturitas"},{"key":"10.1016\/j.jamda.2024.105151_bib35","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/pds.3471","article-title":"Adverse drug reactions in patients with Alzheimer\u2019s disease and related dementia in France: a national multicentre cross-sectional study","volume":"22","author":"Laroche","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jamda.2024.105151_bib36","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1159\/000101454","article-title":"Adverse drug events in cognitively impaired elderly patients","volume":"23","author":"Ganjavi","year":"2007","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.jamda.2024.105151_bib37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1627-4830(06)75270-9","article-title":"Existe-t-il un sur-risque d\u2019accidents m\u00e9dicamenteux chez les sujets \u00e2g\u00e9s atteints de troubles cognitifs","volume":"6","author":"Granjon","year":"2006","journal-title":"NPG Neurol - Psychiatr - G\u00e9riatrie"},{"key":"10.1016\/j.jamda.2024.105151_bib38","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/j.1532-5415.1994.tb06590.x","article-title":"Prevalence of associated diseases in different types of dementia among elderly institutionalized patients: analysis of 3447 records","volume":"42","author":"Holstein","year":"1994","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2024.105151_bib39","doi-asserted-by":"crossref","first-page":"422","DOI":"10.7326\/0003-4819-122-6-199503150-00004","article-title":"Documentation and evaluation of cognitive impairment in elderly primary care patients","volume":"122","author":"Callahan","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jamda.2024.105151_bib40","article-title":"Comorbidity patterns in institutionalized older adults affected by dementia","volume":"14","author":"Zazzara","year":"2022","journal-title":"Alzheimers Dement Amst Neth"},{"key":"10.1016\/j.jamda.2024.105151_bib41","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1046\/j.1532-5415.2002.50084.x","article-title":"Adverse drug reactions in older people with dementia","volume":"50","author":"Akishita","year":"2002","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2024.105151_bib42","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41582-022-00698-7","article-title":"The inter-relationship between delirium and dementia: the importance of delirium prevention","volume":"18","author":"Fong","year":"2022","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jamda.2024.105151_bib43","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.ejim.2015.08.006","article-title":"Under-detection of delirium and impact of neurocognitive deficits on in-hospital mortality among acute geriatric and medical wards","volume":"26","author":"Bellelli","year":"2015","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jamda.2024.105151_bib44","article-title":"Delirium in medically hospitalized patients: prevalence, recognition and risk factors: a prospective cohort study","volume":"12","author":"Al Farsi","year":"2023","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jamda.2024.105151_bib45","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/ageing\/afaa188","article-title":"In-hospital adverse drug reactions in older adults; prevalence, presentation and associated drugs-a systematic review and meta-analysis","volume":"49","author":"Jennings","year":"2020","journal-title":"Age Ageing"},{"key":"10.1016\/j.jamda.2024.105151_bib46","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2165\/00002018-200831010-00003","article-title":"Methods for causality assessment of adverse drug reactions","volume":"31","author":"Agbabiaka","year":"2008","journal-title":"Drug Saf"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861024005735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861024005735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T00:17:01Z","timestamp":1725063421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861024005735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1525861024005735"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2024.105151","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Association of Dementia With Incident Adverse Drug Reactions in Hospitalized Older Adults","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2024.105151","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Post-Acute and Long-Term Care Medical Association.","name":"copyright","label":"Copyright"}],"article-number":"105151"}}